Outsourced Clinical Trials Going Through a Rough Patch

This latest post on BioPharmaLife discusses how the multi-million dollar outsourced clinical trials industry in India is currently going through rough times, as CROs are facing difficulties in recruiting patients and keeping them for the entire period of the trial. There are serious worries since it is estimated that $1 billion will be invested in outsourced clinical trials in India by 2011.

The large volume of people available in India and China make these locations ideal for clinical trials. D Anderson has joined with Clinical Research Education and Management Academy to focus on patient recruitment in the future. The CEO of D Anderson mentions:

"Earlier, we used to recruit patients and retain them till the trial is over but currently the number seemed dwindling. Therefore, in this conference, we are planning a strategised approach."